Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Gilaaaaon May 12, 2016 7:48am

326 Views

Post# 24865066

impresions

I listened to the AGM.

Could some of the people there give me impressions from conversations, nuances, atmosphere, and what was not said. Having to do with :

plasminogen will it get to market and when ?
how do the people in the know feel ?
Are there any that feel that the company has to much to handle (over extended in every way)
are they over optimistic of things to come ?

The positive and the negative please.

many thanks

g